CAI²R Collaborator Guillaume Madelin Awarded with a R03 for Pilot Study

Assistant Professor and CAI2R Research Scientist, Guillaume Madelin, has received NIH funding for his pilot study entitled "Sodium MRI of the Hip". Sodium MRI is a non-invasive technique to quantify glycosaminoglycan (GAG) content in cartilage, which can be used to assess the degradation of cartilage that occurs in Osteoarthritis (OA). Although sodium imaging has immense promise, limitations such as the low concentration, low sensitivity, and fast relaxation time can affect the feasiblity of sodium imaging in most clinical settings. The goal of the pilot study is to develop and optimize the acquisition and reconstruction of quantitative sodium MRI on the hip joint, and to apply the method to subjects with and without OA. This method could be used to develop disease modifying OA drugs, as well as change the way clinicians diagnose OA.


Philanthropic Support

We gratefully acknowledge generous support for radiology research at NYU Langone Health from:
• The Big George Foundation
• Bernard and Irene Schwartz

Go to top